Concepedia

Author

Stefan Klein

Heidelberg UniversityORCID

Also Known As

Klein, Stefan, Klein, Stefan A., S A Klein, S Klein, S. A. Klein, S. Klein, S. Mühldorfer, S., Klein, S.A. Klein, Stefan A Klein

240

Publications

4.3K

Citations

35

H-Index

101

Concepts

All Affiliations

Heidelberg UniversityUniversity Hospital HeidelbergGoethe University FrankfurtUniversity Medical Centre MannheimHeinrich Heine University Düsseldorf
SK

About

Stefan Klein is an author at Heidelberg University specializing in medicine, transplantation, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

33

1.3K

2

Health Sciences

11

11

307

3

Education

1

1

22

4

Natural Sciences

1

1

18

5

Public Health

1

1

21

Stefan Klein

×

88

Publications

3.8K

Citations

32

H-Index

YearCitations

Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry

Stefan Klein, Jürgen Dobmeyer, Thomas S. Dobmeyer,

AIDS

1997

293

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold,

The Lancet

2018

231

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

Thomas Schroeder, Elena Rachlis, Gesine Bug,

Biology of Blood and Marrow Transplantation

2014

198

Assessment of alanine, urea, and glucose interrelationships in normal subjects and in patients with sepsis with stable isotopic tracers.

James H. Shaw, Stefan Klein, Robert R. Wolfe

PubMed

1985

142

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

Volker Heinemann, Ursula Vehling‐Kaiser, Dirk Waldschmidt,

Gut

2012

120

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser,

Journal of Clinical Oncology

2011

116

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

Stefan Boeck, Andreas Jung, Rüdiger P. Laubender,

British Journal of Cancer

2012

115

Ex Vivo Induction of Apoptosis in Lymphocytes Is Mediated by Oxidative Stress: Role for Lymphocyte Loss in HIV Infection

Thomas S. Dobmeyer, Stephan Findhammer, Jürgen Dobmeyer,

Free Radical Biology and Medicine

1997

115

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

Jobst C. von Einem, Volker Heinemann, Ludwig Fischer von Weikersthal,

Journal of Cancer Research and Clinical Oncology

2014

112

Pneumocystis carinii pneumonia in Zimbabwe

Adam Malin, Lovemore Gwanzura, Valerie J. Robertson,

The Lancet

1995

109

Page 1